{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T22:33:03Z","timestamp":1692570783081},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T00:00:00Z","timestamp":1572998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T00:00:00Z","timestamp":1572998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Echocardiogr"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s12574-019-00451-y","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T18:03:12Z","timestamp":1573063392000},"page":"67-72","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Predictors and prognostic impact of secondary mitral regurgitation in myocardial infarction with preserved ejection fraction"],"prefix":"10.1007","volume":"18","author":[{"given":"Maki","family":"Nogi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Okura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,6]]},"reference":[{"issue":"4","key":"451_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.echo.2007.06.002","volume":"21","author":"H Okura","year":"2008","unstructured":"Okura H, Takada Y, Kubo T, et al. Functional mitral regurgitation predicts prognosis independent of left ventricular systolic and diastolic indices in patients with ischemic heart disease. J Am Soc Echocardiogr. 2008;21(4):355\u201360.","journal-title":"J Am Soc Echocardiogr"},{"issue":"9","key":"451_CR2","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1136\/heartjnl-2015-308536","volume":"102","author":"H Okura","year":"2016","unstructured":"Okura H, Kataoka T, Yoshida K. Renin\u2013angiotensin system inhibitors in patients with myocardial infarction and secondary mitral regurgitation. Heart. 2016;102(9):694\u2013700.","journal-title":"Heart"},{"issue":"22","key":"451_CR3","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1016\/j.jacc.2014.02.536","volume":"63","author":"RA Nishimura","year":"2014","unstructured":"Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the american college of cardiology\/american heart association task force on practice guidelines. J Am Coll Cardiol. 2014;63(22):e57\u2013185.","journal-title":"J Am Coll Cardiol"},{"issue":"36","key":"451_CR4","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","volume":"38","author":"H Baumgartner","year":"2017","unstructured":"Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739\u201391.","journal-title":"Eur Heart J"},{"issue":"2","key":"451_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.acvd.2010.04.010","volume":"104","author":"S Marechaux","year":"2011","unstructured":"Marechaux S, Pibarot P, Ennezat PV. Insights into functional mitral regurgitation despite preserved LVEF. Arch Cardiovasc Dis. 2011;104(2):131\u20133.","journal-title":"Arch Cardiovasc Dis."},{"issue":"2","key":"451_CR6","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000350356","volume":"125","author":"PV Ennezat","year":"2013","unstructured":"Ennezat PV, Marechaux S, Pibarot P, et al. Secondary mitral regurgitation in heart failure with reduced or preserved left ventricular ejection fraction. Cardiology. 2013;125(2):110\u20137.","journal-title":"Cardiology"},{"issue":"7","key":"451_CR7","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0894-7317(03)00335-3","volume":"16","author":"WA Zoghbi","year":"2003","unstructured":"Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and doppler echocardiography. J Am Soc Echocardiogr. 2003;16(7):777\u2013802.","journal-title":"J Am Soc Echocardiogr"},{"issue":"6","key":"451_CR8","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1161\/01.CIR.96.6.1999","volume":"96","author":"Y Otsuji","year":"1997","unstructured":"Otsuji Y, Handschumacher MD, Schwammenthal E, et al. Insights from three-dimensional echocardiography into the mechanism of functional mitral regurgitation: direct in vivo demonstration of altered leaflet tethering geometry. Circulation. 1997;96(6):1999\u20132008.","journal-title":"Circulation"},{"issue":"2","key":"451_CR9","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0735-1097(00)01134-7","volume":"37","author":"Y Otsuji","year":"2001","unstructured":"Otsuji Y, Handschumacher MD, Liel-Cohen N, et al. Mechanism of ischemic mitral regurgitation with segmental left ventricular dysfunction: three-dimensional echocardiographic studies in models of acute and chronic progressive regurgitation. J Am Coll Cardiol. 2001;37(2):641\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"451_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jcmg.2011.10.004","volume":"5","author":"K Saito","year":"2012","unstructured":"Saito K, Okura H, Watanabe N, et al. Influence of chronic tethering of the mitral valve on mitral leaflet size and coaptation in functional mitral regurgitation. JACC Cardiovasc Imaging. 2012;5(4):337\u201345.","journal-title":"JACC Cardiovasc Imaging."},{"issue":"10","key":"451_CR11","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. randomized aldactone evaluation study investigators. N Engl J Med. 1999;341(10):709\u201317.","journal-title":"N Engl J Med"},{"issue":"23","key":"451_CR12","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1161\/01.CIR.100.23.2312","volume":"100","author":"M Packer","year":"1999","unstructured":"Packer M, Poole-Wilson PA, Armstrong PW, et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. Circulation. 1999;100(23):2312\u20138.","journal-title":"Circulation"},{"issue":"1","key":"451_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1009492","volume":"364","author":"F Zannad","year":"2011","unstructured":"Zannad F, McMurray JJ, Krum H, et al. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med. 2011;364(1):11\u201321.","journal-title":"N Engl J Med"},{"issue":"3","key":"451_CR14","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1056\/NEJMoa051530","volume":"355","author":"RS Bhatia","year":"2006","unstructured":"Bhatia RS, Tu JV, Lee DS, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006;355(3):260\u20139.","journal-title":"N Engl J Med"},{"issue":"19","key":"451_CR15","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","volume":"27","author":"JG Cleland","year":"2006","unstructured":"Cleland JG, Tendera M, Adamus J, et al. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J. 2006;27(19):2338\u201345.","journal-title":"Eur Heart J"},{"issue":"23","key":"451_CR16","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","volume":"359","author":"BM Massie","year":"2008","unstructured":"Massie BM, Carson PE, McMurray JJ, et al. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med. 2008;359(23):2456\u201367.","journal-title":"N Engl J Med"},{"issue":"5","key":"451_CR17","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.jacc.2004.11.048","volume":"45","author":"N Watanabe","year":"2005","unstructured":"Watanabe N, Ogasawara Y, Yamaura Y, et al. Quantitation of mitral valve tenting in ischemic mitral regurgitation by transthoracic real-time three-dimensional echocardiography. J Am Coll Cardiol. 2005;45(5):763\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"451_CR18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jjcc.2008.09.005","volume":"53","author":"R Yamada","year":"2009","unstructured":"Yamada R, Watanabe N, Kume T, et al. Quantitative measurement of mitral valve coaptation in functional mitral regurgitation: in vivo experimental study by real-time three-dimensional echocardiography. J Cardiol. 2009;53(1):94\u2013101.","journal-title":"J Cardiol"},{"issue":"4","key":"451_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s12574-011-0091-z","volume":"9","author":"K Saito","year":"2011","unstructured":"Saito K, Okura H, Watanabe N, et al. Quantification of mitral valve apparatus by three-dimensional transesophageal echocardiography: in vitro validation study comparing two different analysis systems. J Echocardiogr. 2011;9(4):130\u20136.","journal-title":"J Echocardiogr."},{"issue":"6","key":"451_CR20","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jjcc.2017.03.013","volume":"70","author":"K Ito","year":"2017","unstructured":"Ito K, Abe Y, Takahashi Y, et al. Mechanism of atrial functional mitral regurgitation in patients with atrial fibrillation: a study using three-dimensional transesophageal echocardiography. J Cardiol. 2017;70(6):584\u201390.","journal-title":"J Cardiol"},{"issue":"5","key":"451_CR21","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1253\/circj.CJ-17-1334","volume":"82","author":"Y Abe","year":"2018","unstructured":"Abe Y, Akamatsu K, Ito K, et al. Prevalence and prognostic significance of functional mitral and tricuspid regurgitation despite preserved left ventricular ejection fraction in atrial fibrillation patients. Circ J. 2018;82(5):1451\u20138.","journal-title":"Circ J"},{"issue":"13","key":"451_CR22","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1161\/01.CIR.103.13.1759","volume":"103","author":"F Grigioni","year":"2001","unstructured":"Grigioni F, Enriquez-Sarano M, Zehr KJ, et al. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation. 2001;103(13):1759\u201364.","journal-title":"Circulation"},{"issue":"5","key":"451_CR23","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/S0003-4975(02)03920-6","volume":"74","author":"KM Harris","year":"2002","unstructured":"Harris KM, Sundt TM 3rd, Aeppli D, et al. Can late survival of patients with moderate ischemic mitral regurgitation be impacted by intervention on the valve? Ann Thorac Surg. 2002;74(5):1468\u201375.","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"451_CR24","doi-asserted-by":"publisher","first-page":"e000637","DOI":"10.1136\/openhrt-2017-000637","volume":"4","author":"K Kim","year":"2017","unstructured":"Kim K, Kaji S, Kasamoto M, et al. Renin\u2013angiotensin system inhibitors in patients with or without ischaemic mitral regurgitation after acute myocardial infarction. Open Heart. 2017;4(2):e000637.","journal-title":"Open Heart."},{"issue":"9","key":"451_CR25","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1093\/eurjhf\/hfs079","volume":"14","author":"S Baldus","year":"2012","unstructured":"Baldus S, Schillinger W, Franzen O, et al. MitraClip therapy in daily clinical practice: initial results from the German transcatheter mitral valve interventions (TRAMI) registry. Eur J Heart Fail. 2012;14(9):1050\u20135.","journal-title":"Eur J Heart Fail"}],"container-title":["Journal of Echocardiography"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12574-019-00451-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12574-019-00451-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12574-019-00451-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:45:33Z","timestamp":1604537133000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12574-019-00451-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,6]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["451"],"URL":"https:\/\/doi.org\/10.1007\/s12574-019-00451-y","relation":{},"ISSN":["1349-0222","1880-344X"],"issn-type":[{"value":"1349-0222","type":"print"},{"value":"1880-344X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,6]]},"assertion":[{"value":"31 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Maki Nogi, Hiroyuki Okura, Toru Kataoka and Kiyoshi Yoshida declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later revisions. Informed consent for echocardiographic examination was obtained from all patients. As described in the methods section, informed consent for being included in this specific study was not obtained because the ethical committee of the institution (Bell Land General Hospital) did not require either approval by the committee or informed consent from the patients for this retrospective observational analysis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human rights statements and informed consent"}}]}}